ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Clomiphene (Clomid) vs Testosterone Replacement Comparison Study
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 18413" data-attributes="member: 3"><p>Abstracts printed from AUA2015.org</p><hr /><p><strong>COMPARISON OF THE EFFICACY OF CLOMIPHENE CITRATE VERSUS TESTOSTERONE SUPPLEMENTATION IN TREATING SYMPTOMS OF HYPOGONADISM</strong></p><p><strong>Authors:</strong> Nathan Wilken, Jason Scovell, Ranjith Ramasamy*, Dolores Lamb, Larry Lipshultz, Houston, TX</p><p><strong>Abstract: PD45-02</strong> </p><p><strong>Introduction and Objectives</strong> </p><p>We sought to compare satisfaction and treatment efficacy in men (age range 35 to 75) with symptomatic hypogonadism (total testosterone < 300ng/dL and > 3 (+) symptoms on the Androgen Deficiency in the Aging Male - ADAM questionnaire) before and after receiving testosterone supplementation. </p><p></p><p><strong>Methods</strong> </p><p>We prospectively followed a total of 52 men on T injections and T gels (n=27 on injections, n=25 on gel) and 23 men on clomiphene citrate (CC, 25mg once a day) from 2013 - 2014. These men were then age-matched to eugonadal men (T > 300ng/dL and < 3 (+) symptoms on ADAM) with a similar comorbidity profile who were not on CC or TST (controls) followed during the same time period. Comparisons were made between baseline and post-treatment variables, and multivariable analysis was conducted to define predictors of successful response to CC or TST (age, comorbidities, TST modality, and hormone levels). </p><p></p><p><strong>Results</strong> </p><p>Median serum total testosterone increased from pre-treatment levels in all men (p<0.05), regardless of therapy type (T injections= 252.5 to 606 ng/dL, T gels= 263 to 445.5ng/dL, CC 235.5 to 438 ng/dL). Men taking TST reported fewer ADAM symptoms after treatment (5 to 2, p < 0.05). Similarly, men taking CC reported fewer ADAM symptoms after treatment (3 to 1, p < 0.05). Conversely, eugonadal men had similar T levels (352.1 vs. 364.3) and hypogonadal symptoms (1.5 vs. 1.4) before and after follow-up. When the types of hypogonadal symptoms were evaluated, both sexual, and psychological symptoms responded to CC or TST. However, physical symptoms did not appear to improve with therapy. A similar proportion of men receiving TST responded (> 3 symptoms improved on ADAM) to therapy (52%) as compared to men who received CC (44%). On multivariable analysis, only younger age was positively associated with response to therapy (OR = 6.449, p = 0.02). Interestingly, neither modality of therapy (T injections vs. T gels vs. CC) nor post-treatment testosterone levels were associated with symptom improvement. Some strengths of this study include the prospective design, availability of control group, and comparisons of symptoms and hormone levels before and after commencement of CC and TST. The study is limited by its relatively small sample size and short follow-up (~ 3.5 months). </p><p></p><p><strong>Conclusions</strong> </p><p>Testosterone supplementation and clomiphene citrate regimens are efficacious for improving both hypogonadal symptoms and serum total testosterone levels. Clearly, younger men appear to respond better following therapy for hypogonadism.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 18413, member: 3"] Abstracts printed from AUA2015.org [HR][/HR][B]COMPARISON OF THE EFFICACY OF CLOMIPHENE CITRATE VERSUS TESTOSTERONE SUPPLEMENTATION IN TREATING SYMPTOMS OF HYPOGONADISM[/B] [B]Authors:[/B] Nathan Wilken, Jason Scovell, Ranjith Ramasamy*, Dolores Lamb, Larry Lipshultz, Houston, TX [B]Abstract: PD45-02[/B] [B]Introduction and Objectives[/B] We sought to compare satisfaction and treatment efficacy in men (age range 35 to 75) with symptomatic hypogonadism (total testosterone < 300ng/dL and > 3 (+) symptoms on the Androgen Deficiency in the Aging Male - ADAM questionnaire) before and after receiving testosterone supplementation. [B]Methods[/B] We prospectively followed a total of 52 men on T injections and T gels (n=27 on injections, n=25 on gel) and 23 men on clomiphene citrate (CC, 25mg once a day) from 2013 - 2014. These men were then age-matched to eugonadal men (T > 300ng/dL and < 3 (+) symptoms on ADAM) with a similar comorbidity profile who were not on CC or TST (controls) followed during the same time period. Comparisons were made between baseline and post-treatment variables, and multivariable analysis was conducted to define predictors of successful response to CC or TST (age, comorbidities, TST modality, and hormone levels). [B]Results[/B] Median serum total testosterone increased from pre-treatment levels in all men (p<0.05), regardless of therapy type (T injections= 252.5 to 606 ng/dL, T gels= 263 to 445.5ng/dL, CC 235.5 to 438 ng/dL). Men taking TST reported fewer ADAM symptoms after treatment (5 to 2, p < 0.05). Similarly, men taking CC reported fewer ADAM symptoms after treatment (3 to 1, p < 0.05). Conversely, eugonadal men had similar T levels (352.1 vs. 364.3) and hypogonadal symptoms (1.5 vs. 1.4) before and after follow-up. When the types of hypogonadal symptoms were evaluated, both sexual, and psychological symptoms responded to CC or TST. However, physical symptoms did not appear to improve with therapy. A similar proportion of men receiving TST responded (> 3 symptoms improved on ADAM) to therapy (52%) as compared to men who received CC (44%). On multivariable analysis, only younger age was positively associated with response to therapy (OR = 6.449, p = 0.02). Interestingly, neither modality of therapy (T injections vs. T gels vs. CC) nor post-treatment testosterone levels were associated with symptom improvement. Some strengths of this study include the prospective design, availability of control group, and comparisons of symptoms and hormone levels before and after commencement of CC and TST. The study is limited by its relatively small sample size and short follow-up (~ 3.5 months). [B]Conclusions[/B] Testosterone supplementation and clomiphene citrate regimens are efficacious for improving both hypogonadal symptoms and serum total testosterone levels. Clearly, younger men appear to respond better following therapy for hypogonadism. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Clomiphene (Clomid) vs Testosterone Replacement Comparison Study
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top